Plott Ronald Todd
Known title: DirectorCIK: 0001768337
Plott Ronald Todd's purchase track record
Plott Ronald Todd has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/28/2026 | PHIO | $10K | pending | pending | — |
| 8/19/2026 | PHIO | $17K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PHIO | ▲ Buy | Open Market | 5,000 | $5K | 9/29/2026 | View on chart |
| PHIO | ▲ Buy | Open Market | 5,000 | $5K | 9/28/2026 | View on chart |
| PHIO | ▲ Buy | Grant | 17,000 | $0 | 9/28/2026 | View on chart |
| PHIO | ▲ Buy | Open Market | 15,000 | $17K | 8/19/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum
Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum. Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.